In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out
Understanding the core differences between semaglutide and tirzepatide helps contextualize why the transition requires careful management of timing, and why the side effect profiles differ
"When you start taking this medication, your body almost goes into shock - you get headaches, nausea, tiredness," she explains
What Happens When You Microdose GLP-1 Medications
This peptide functions as a dual receptor agonist, binding both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors thereby While there are many online options, getting tirzepatide through Diehl Plastic Surgery in Raleigh has many advantages
